Kyntra Bio (KYNB) Other Non-Current Liabilities (2013 - 2026)
Kyntra Bio (KYNB) posted Other Non-Current Liabilities of $67,000 for Q2 2026, down 36.8% from $106,000 a year earlier and down 11.8% from the prior quarter.
Kyntra Bio (KYNB) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Kyntra Bio's Other Non-Current Liabilities came in at $82,000, down 90.0% from FY2024.
- Annual Other Non-Current Liabilities has declined for six consecutive years, with a five-year compound annual growth rate of -70.8% (FY2020 to FY2025).
- In prior years, Kyntra Bio's Other Non-Current Liabilities was $822,000 in FY2024 (-71.2%), $2.86 million in FY2023 (-55.6%), $6.44 million in FY2022 (-75.3%) and $26.02 million in FY2021 (-32.9%).
- The Q2 2026 figure stands as the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2014.
- On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last 23 quarters, with an average decline of 78.1% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Non-Current Liabilities ran from 32.9% in Q4 2021 to 90.8% in Q1 2026.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $76,000 (Q1 2026), $82,000 (Q4 2025) and $98,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Kyntra Bio | 12.57 Mn | -395.37 Mn | 1.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 830,000.00 |
| Dec 31, 2024 | 822,000.00 |
| Sep 30, 2024 | 837,000.00 |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 3.79 Mn |
| Dec 31, 2023 | 2.86 Mn |
| Sep 30, 2023 | 4.26 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 14.30 Mn |
| Jun 30, 2022 | 17.83 Mn |
| Mar 31, 2022 | 24.33 Mn |
| Dec 31, 2021 | 26.02 Mn |
| Sep 30, 2021 | 24.32 Mn |
Kyntra Bio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KYNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();